Neurocrine Biosciences
NBIX
#1672
Rank
โ‚ฌ11.09 B
Marketcap
110,60ย โ‚ฌ
Share price
1.34%
Change (1 day)
0.87%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚ฌ1.17 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are โ‚ฌ1.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ1.17 B8.15%
2024-12-31โ‚ฌ1.08 B17.65%
2023-12-31โ‚ฌ0.92 B49.67%
2022-12-31โ‚ฌ0.61 B-0.11%
2021-12-31โ‚ฌ0.61 B24.67%
2020-12-31โ‚ฌ0.49 B-17.17%
2019-12-31โ‚ฌ0.59 B33.36%
2018-12-31โ‚ฌ0.44 B20.64%
2017-12-31โ‚ฌ0.37 B677.76%
2016-12-31โ‚ฌ47.73 M3.7%
2015-12-31โ‚ฌ46.03 M63.06%
2014-12-31โ‚ฌ28.23 M13.78%
2013-12-31โ‚ฌ24.81 M-21.12%
2012-12-31โ‚ฌ31.45 M-47.82%
2011-12-31โ‚ฌ60.28 M-35.89%
2010-12-31โ‚ฌ94.03 M101.49%
2009-12-31โ‚ฌ46.66 M-19.86%
2008-12-31โ‚ฌ58.23 M-46.17%
2007-12-31โ‚ฌ0.10 B90.43%
2006-12-31โ‚ฌ56.81 M-27.65%
2005-12-31โ‚ฌ78.52 M-15.05%
2004-12-31โ‚ฌ92.43 M-28.97%
2003-12-31โ‚ฌ0.13 B221.7%
2002-12-31โ‚ฌ40.45 M-0.65%
2001-12-31โ‚ฌ40.71 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ98.30 B 8,289.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ116.03 B 9,802.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ73.05 B 6,134.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚ฌ0.71 B-39.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ37.25 M-96.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.76 B-34.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ6.98 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ8.42 B 618.65%๐Ÿ‡ฌ๐Ÿ‡ง UK